Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
QuintilesIMS
Citi
UBS
Teva
Deloitte
Dow
Fish and Richardson
Chubb
Julphar

Generated: January 18, 2018

DrugPatentWatch Database Preview

METAPROTERENOL SULFATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for metaproterenol sulfate and what is the scope of metaproterenol sulfate freedom to operate?

Metaproterenol sulfate
is the generic ingredient in three branded drugs marketed by Boehringer Ingelheim, Apotex Inc, Astrazeneca, DEY, Mylan Speciality Lp, Nephron, Wockhardt, Muro, G And W Labs Inc, Morton Grove, Silarx, Am Therap, Par Pharm, Teva, Usl Pharma, and Watson Labs, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for metaproterenol sulfate. Two suppliers are listed for this compound.
Pharmacology for METAPROTERENOL SULFATE
Medical Subject Heading (MeSH) Categories for METAPROTERENOL SULFATE

US Patents and Regulatory Information for METAPROTERENOL SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva METAPROTERENOL SULFATE metaproterenol sulfate TABLET;ORAL 072519-001 Mar 30, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Muro PROMETA metaproterenol sulfate SYRUP;ORAL 072023-001 Sep 15, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Morton Grove METAPROTERENOL SULFATE metaproterenol sulfate SYRUP;ORAL 071656-001 Oct 13, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Silarx METAPROTERENOL SULFATE metaproterenol sulfate SYRUP;ORAL 073632-001 Jul 22, 1992 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp METAPROTERENOL SULFATE metaproterenol sulfate SOLUTION;INHALATION 070804-001 Aug 17, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Muro PROMETA metaproterenol sulfate SOLUTION;INHALATION 073340-001 Mar 30, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nephron METAPROTERENOL SULFATE metaproterenol sulfate SOLUTION;INHALATION 071855-001 Jul 14, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 018761-001 Jun 30, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt METAPROTERENOL SULFATE metaproterenol sulfate SOLUTION;INHALATION 072190-001 Jun 7, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim ALUPENT metaproterenol sulfate SYRUP;ORAL 017571-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for METAPROTERENOL SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim ALUPENT metaproterenol sulfate AEROSOL, METERED;INHALATION 016402-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 018761-001 Jun 30, 1983 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim ALUPENT metaproterenol sulfate SYRUP;ORAL 017571-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 017659-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Chubb
Daiichi Sankyo
McKesson
Fuji
Moodys
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot